AHA scientific statement. Magnetic resonance angiography : update on applications for extracranial arteries

Whole-body magnetic resonance angiography of patients using a standard clinical scanner

The purpose of this study was to evaluate the technique of whole-body magnetic resonance angiography (MRA) of patients with a standard clinical scanner. Thirty-three patients referred for stenoses, occlusions, aneurysms, assessment of patency of vascular grafts, vasculitis and vascular aplasia were examined in a 1.5-T scanner using its standard body coil. Three-dimensional sequences were acquired in four stations after administration of one intravenous injection of 40 ml conventional gadolinium contrast agent. Different vessel segments were evaluated as either diagnostic or nondiagnostic and regarding the presence of stenoses with more than 50% diameter reduction, occlusions or aneurysms. Of 923 vessel segments, 67 were not evaluable because of poor contrast filling (n=31), motion artefacts (n=20), venous overlap (n=12) and other reasons (n=4). Stenoses of more than 50%, occlusions or aneurysms were observed in 26 patients (129 segments). In nine patients additional unsuspected pathology was found. In 10 out of 14 patients (71/79 segments) there was conformity between MRA and digital subtraction angiography regarding the grade of stenosis. This study shows that whole-body MRA with a standard clinical scanner is feasible. Motion artefacts and the timing of the contrast agent through the different segments are still problems to be solved.

Utility of contrast-enhanced 3D turbo-flash MR angiography in evaluating the intracranial venous system

The objective of this study was to compare the effectiveness of contrast-enhanced 3D turbo-flash and 2D time-of-flight (TOF) magnetic resonance angiography (MRA) sequences in the visualization and evaluation of the intracranial venous system. A prospective study was carried out on 41 patients referred to our Magnetic Resonance Imaging (MRI) unit with clinical findings suggestive of dural sinus thrombosis. Contrast-enhanced 3D turbo-flash and 2D TOF MRA sequences were performed, and the dural sinuses and cerebral veins were classified into five grades according to the quality of visualization and presence of thrombosis. We found the dural sinuses and cerebral veins to be normal in all sequences in 31 patients. Thrombosis of dural sinuses was detected in ten patients, with four of these ten cases found only in the contrast-enhanced 3D turbo-flash sequence. In general, complete visualization of cerebral veins and dural sinuses was significantly better accomplished with contrast-enhanced 3D turbo-flash MRA than with 2D TOF in either coronal or sagittal/oblique planes. Although 2D TOF MRA may be superior in detecting chronic dural sinus thrombosis, contrast-enhanced 3D turbo-flash MRA sequences may offer advantages for the early diagnosis and management of acute and subacute dural sinus thrombosis.

Magnetic resonance imaging of atherosclerosis

Abundant data now link composition of the vascular wall, rather than the degree of luminal narrowing, with the risk for acute ischemic syndromes in the coronary, central nervous system, and peripheral arterial beds. Over the past few years, magnetic resonance angiography has evolved as a well-established method to determine the location and severity of advanced, lumen-encroaching atherosclerotic lesions. In addition, more recent studies have shown that high spatial resolution, multisequence MRI is also a promising tool for noninvasive, serial imaging of the aortic and carotid vessel wall, which potentially can be applied in the clinical setting. Because of the limited spatial resolution of current MRI techniques, characterization of coronary vessel wall atherosclerosis, however, is not yet possible and remains the holy grail of plaque imaging. Recent technical developments in MRI technology such as dedicated surface coils, the introduction of 3.0-T high-field systems and parallel imaging, as well as developments in the field of molecular imaging such as contrast agents targeted to specific plaque constituents, are likely to lead to the necessary improvements in signal to noise ratio, imaging speed, and specificity. These improvements will ultimately lead to more widespread application of this technology in clinical practice. In the present review, the current status and future role of MRI for plaque detection and characterization are summarized.

Magnetic resonance imaging of the peripheral vasculature

BACKGROUND

Atherosclerotic disease of the peripheral vasculature is a prevalent condition for which catheter-based techniques have been considered to be the gold standard for diagnosis. However, because of their invasive nature, these techniques inherently have the potential for complications. Non-invasive diagnostic techniques have historically been limited by low accuracy and high operator dependence. Magnetic resonance angiography (MRA) is a new approach that has diagnostic accuracy comparable with invasive angiography.

METHODS

The literature on MRA for evaluation of carotid, mesenteric, renal, and lower-extremity arterial disease was extensively reviewed. Helpful diagnostic algorithms on the basis of the literature are also provided.

RESULTS

MRA is both sensitive and specific when compared with invasive angiography for the evaluation of peripheral arterial disease and avoids the potential for complications resulting from arterial puncture and use of iodinated contrast.

CONCLUSION

Current MRA techniques are diagnostically robust and have proven to be a highly accurate, safe, and convenient means of diagnosing atherosclerotic disease of the peripheral vascular system.

CT and MR imaging of the thoracic aorta: current techniques and clinical applications

Disease of the thoracic aorta can present with a broad clinical spectrum of symptoms and signs. The accepted diagnostic gold standard, selective digital subtraction angiography, is now being challenged by state-of-the-art CT angiography (CTA) and MR angiography(MRA). Currently, in many centers, cross-sectional imaging modalities are being used as the first line of diagnosis to evaluate the cardiovascular system, and conventional angiography is reserved for therapeutic intervention. Understanding the principles of CTA and MRA techniques is essential to acquire diagnostic images consistently. This article reviews current CTA and MRA methods used in the evaluation of thoracic aortic disease.

Performance of steady-state free precession for imaging carotid artery disease

PURPOSE

To evaluate steady-state free precession (SSFP) for diagnosing carotid artery disease.

MATERIALS AND METHODS

Following bilateral x-ray angiography, seven patients with suspected carotid artery disease were imaged with SSFP, black blood fast spin echo (BB FSE), and time-of-flight MR angiography (TOF MRA). The techniques were compared for characterizing the vessel lumen. Flow phantom experiments were also performed, using speeds of 0 to 40 cm/second, to further evaluate the merits of each MR technique.

RESULTS

In the patient studies, of the 14 arteries available, a correct grading of stenosis was possible with SSFP in 9 of 14, FSE in 12 of 14, and TOF in 13 of 14, assuming x-ray angiography as the gold standard. The SSFP technique was the least reliable and had severe artifacts in 5 of 14 arteries, making these images nondiagnostic. The flow phantom demonstrated that although the SSFP technique performs well under slow or no flow, it breaks down at higher flow levels.

CONCLUSION

The continuous SSFP sequence used here was not reliable for imaging carotid artery disease owing to artifact in many cases. Nevertheless, the high speed of this SSFP technique does allow it to serve as a rapid scouting method prior to a more detailed evaluation with other MRI methods.

Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience

PURPOSE

To determine whether higher concentrated gadolinium chelates are advantageous for the recently introduced concept of total-body magnetic resonance angiography (MRA), allowing whole-body coverage, extending from the carotid arteries to the runoff vessels, in merely 72 seconds.

MATERIALS AND METHODS

Total-body three-dimensional (3D) MRA using a 1 M Gd-chelate (gadobutrol, Gadovist, Schering, Berlin, Germany) at a dosage of 0.2 mmol/kg body-weight (biphasic injection protocol: 1.3 mL/second and 0.7 mL/second) was performed on three healthy volunteers and ten consecutive patients with DSA-documented peripheral vascular disease. Separated by at least 72 hours, the three healthy volunteers also underwent the same MRA-protocol, using gadopentetate dimeglumine in equimolar dosages.

RESULTS

Compared to equimolar dosages, mean signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) values in the three volunteers were significantly higher (up to 32.5% for the arteries of the thighs and calves) using gadobutrol. In the ten patients, gadobutrol-based total-body MRA accurately assessed significant stenoses (luminal narrowing > 50%) with sensitivities and specificities of 96.2% (95% CI 0.83-0.97) and 95.7% (95% CI 0.84-0.96), respectively, compared to digital subtraction angiography.

CONCLUSION

The MRA image quality for total-body MRA provided by the administration of gadobutrol is superior to that obtained following administration of an identical dose of gadopentetate dimeglumine, and therefore shows promise for use as a comprehensive single exam assessing the entire arterial system for the presence of atherosclerotic disease manifestations.

Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography

PURPOSE

To evaluate a simplified protocol by using free-breathing three-dimensional (3D) coronary magnetic resonance (MR) angiography to determine the anatomy of anomalous coronary arteries, in particular the relationship of the vessels to the aortic root.

MATERIALS AND METHODS

Twenty-six patients (18 men, eight women; mean age, 50 years; age range, 18-77 years) who had a history of chest pain, palpitations, or syncope and who were suspected of having coronary artery anomalies were examined with free-breathing MR angiography. Multiple 3D volume slabs were acquired at the level of the sinuses of Valsalva by using diaphragmatic navigators for respiratory artifact suppression. The proximal anatomy of the coronary arteries was determined.

RESULTS

Six anomalous circumflex arteries originated from the right sinus of Valsalva and passed behind the aortic root. Six right coronary arteries arose from the left sinus of Valsalva and coursed between the aortic root and the right ventricular outflow tract (RVOT). Nine left coronary arteries arose from the right sinus of Valsalva; seven of nine coursed between the aortic root and the RVOT. Five patients had minor anomalies. Overall, in eight patients with anomalous arteries that coursed between the aortic root and the RVOT, conventional coronary angiography could not be used confidently to identify the proximal course.

CONCLUSION

Free-breathing 3D coronary MR angiography can be used to identify the proximal anatomy of anomalous coronary arteries.

Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography

PURPOSE

To compare the diagnostic accuracy of gadobenate dimeglumine (Gd-BOPTA)-enhanced versus gadoterate meglumine (Gd-DOTA)-enhanced magnetic resonance (MR) angiography in patients with peripheral arterial occlusive disease (PAOD).

MATERIALS AND METHODS

Fifty-six patients underwent MR angiography enhanced with either Gd-DOTA (28 patients) or Gd-BOPTA (28 patients). All arterial segments from the renal arteries to the distal run-off vessels were evaluated for disease severity. The sensitivity, specificity, and accuracy of MR angiography enhanced with both agents separately were evaluated with a paired t test; digital subtraction angiography was the reference standard. Interobserver variability was assessed by using the Cohen test.

RESULTS

Diagnostic MR angiograms were obtained in all 56 patients. Overall, sensitivity and specificity of Gd-DOTA-enhanced MR angiography were 96% and 93%, respectively, for observer 1 and 96% and 85%, respectively, for observer 2 (kappa = 0.82). Corresponding values for Gd-BOPTA-enhanced MR angiography were 94% and 93%, respectively, for observer 1 and 94% and 89%, respectively, for observer 2 (kappa = 0.78). No consistent differences between the two contrast materials in assessment of PAOD in the renal to popliteal arteries were observed. For assessment below the knee, specificity was slightly higher in the Gd-BOPTA group-91% and 84% for observers 1 and 2, respectively-than in the Gd-DOTA group-89% and 77%, respectively (P <.01). The number of nonassessable below-the-knee segments was significantly lower in the Gd-BOPTA group: nine of 299 segments versus 25 of 312 segments in the Gd-DOTA group (P <.01).

CONCLUSION

At MR angiography of the distal run-off vessels, Gd-BOPTA yielded higher specificity and a significantly smaller number of nonassessable segments than Gd-DOTA. The diagnostic accuracy of the two gadolinium chelates at peripheral MR angiography was comparable in the renal to popliteal arteries.

MR angiography of the abdominal aorta and peripheral vessels

Contrast-enhanced MRA can be an accurate and reliable method for the arterial evaluation of the abdominal aorta and peripheral vessels. This technique can be adapted for a variety of anatomic regions. The basic issues relate to proper synchronization of imaging with peak arterial enhancement and to optimization of voxel dimensions for adequate depiction of the arterial structures.

MR imaging of atherosclerotic plaque

MRI is a powerful noninvasive imaging tool with high spatial resolution that continues to prove its value in determining atherosclerotic plaque size, volume, and tissue components. Multispectral MRI sequences have been validated to characterize atherosclerotic plaque components in animals; they have recently been applied to human aorta and carotid artery and are being used to identify the vulnerable plaque. The ability to measure wall thickness in human coronary artery wall has been realized. Future developments may allow plaque characterization in the coronary arteries with surface coil imaging, but intravascular MRI may play an important role in this regard. Novel contrast agents for identifying inflammation and thrombus within atherosclerotic plaque will aid in the identification of higher-risk atherosclerotic disease. Lastly, MRI has progressed to the point where it can be used in serial studies of atherosclerotic plaque progression and regression in the face of therapeutic intervention. MRI will continue to evolve an important role in imaging of atherosclerotic plaque.

Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies

OBJECTIVE

The goal of this study was to evaluate the diagnostic value of gadolinium (Gd)-enhanced three-dimensional (3D) magnetic resonance angiography (MRA) in patients with congenital and acquired anomalies of the pulmonary and systemic veins.

BACKGROUND

Gadolinium-enhanced 3D MRA is a fast magnetic resonance imaging technique that has shown great promise in the evaluation of large and medium-sized arteries. However, its application to venous anomalies has not been studied in detail.

METHODS

The study retrospectively analyzed all patients who underwent Gd-enhanced 3D MRA examination from January 1998 through January 2001, were diagnosed with anomalies of the pulmonary or systemic veins and had additional diagnostic data available for comparison with the MRA findings.

RESULTS

Sixty-one patients (age 1 day to 60 years) were included. Image acquisition was completed in 29 +/- 6.9 s. Pulmonary venous anomalies were found in 37 patients, systemic venous anomalies in 17 patients and both pulmonary and systemic venous anomalies in 7 patients. Compared with available diagnostic information by other modalities, all known or suspected venous anomalies were imaged by 3D MRA. In three patients, catheterization did not detect anomalies of the pulmonary veins that were subsequently diagnosed by MRA. The 3D MRA diagnoses were followed by 10 interventional catheterization procedures and 15 operations. In 74% of patients, 3D MRA either diagnosed previously unsuspected venous anomalies (28%) or added new clinically important information (46%). The mechanism of pulmonary vein compression in eight patients was determined by MRA but not by other imaging modalities. Using a five-level grading system for MRA image quality (1 = nondiagnostic; 5 = excellent), the average grade was 4.6 +/- 0.6, with a 0.28 +/- 0.6 mean grade difference between two independent observers.

CONCLUSIONS

Gadolinium-enhanced 3D MRA is capable of rapidly and accurately diagnosing a wide spectrum of pulmonary and systemic venous anomalies and is a useful noninvasive alternative to diagnostic catheterization.

Combining Time-resolved and Single-phase 3D Techniques in Contrast-enhanced Carotid MR Angiography

We established an easy-to-use technique for performing contrast-enhanced carotid MR angiography (MRA) with a commercial scanner. Twenty-three patients with suspected carotid or vertebral arterial lesions were prospectively studied. Two techniques were applied in the study. After performing sagittal time-resolved acquisitions, we undertook a coronal single-phase 3D acquisition, in which the injection timing was estimated from the preceding images. In each case, we obtained multidirectional images with sufficient venous suppression. The combined use of time-resolved and single-phase 3D MRA is a feasible technique for obtaining selective arterial images without the use of special applications or hardware.

18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors

It has been reported that there is a high correlation between fluorodeoxyglucose (FDG) uptake in the aorta and macrophage content of atherosclerotic lesions in an experimental rabbit model. We evaluated the frequency of FDG uptake in the large arteries in relation to the atherogenic risk factors. We also investigated whether FDG uptake of the large arteries is related to clinically known coronary artery disease. The presence of FDG uptake was assessed in the abdominal aorta (AA), iliac (IA), and proximal femoral arteries (FAs) in 156 patients. Medical history of the atherogenic risk factors (age, cigarette smoking, hypertension, diabetes, high cholesterol, and obesity) and coronary artery disease (CAD) was identified for each patient. The frequency of vascular FDG uptake was compared between the patients without risk factors (Group I, 23 patients) and those with at least 1 risk factor (Group II, 133 patients). The correlation of each risk factor and known CAD with arterial FDG uptake was also assessed in the 3 different arteries. There was a significant difference in the frequency of FDG uptake between the 2 groups for the FA (22% vs 70%) and IA (30% vs 54%), but not for the AA (35% vs 53%). Among all risk factors, age was the most significant and consistent factor correlating with FDG uptake in all 3 arteries. Hypercholesterolemia also correlated consistently with FDG uptake in all 3 arteries. The correlation between the remaining risk factors and arterial FDG uptake was rather artery specific than consistent throughout all 3 arteries. A higher frequency of FDG uptake in the FA was seen in patients with CAD compared with those without CAD. Not all risk factors correlated with FDG uptake in different arteries. Among the risk factors, age and hypercholesterolemia most consistently correlated with FDG uptake in the AA, and the IA and proximal FAs. The positive correlation of arterial FDG uptake with the atherogenic risk factors suggested a promising role for FDG-PET imaging in the diagnosis of atherosclerosis and follow-up after treatment intervention.

Magnetic resonance imaging of thoracic aortic aneurysm and dissection

MRI is an extremely useful technique for the evaluation of the thoracic aorta. It provides a comprehensive evaluation of all the important structures within the chest and allows for high-resolution imaging of both the aortic lumen and the wall itself. As such, it is a sensitive method for delineating the extent of disease, branch-vessel involvement, and superimposed complications. Technical advances, such as stepped-table MRA and bolus-timing strategies, continue to improve overall image quality. In addition, the recent development of blood-pool contrast agents may further impact the diagnostic yield. Given these facts, MRI is likely to remain a mainstay in this patient population for years to come.

Magnetic resonance angiography and evaluation of cervical arteries

Multiple clinical trials have demonstrated the efficacy of endarterectomy in selected groups of patients based primarily on percent diameter stenosis. Although measurement of stenosis in the clinical trials was established by conventional angiography, there is considerable interest in noninvasive alternatives. Magnetic resonance angiography, performed using time-of-flight methods or with contrast enhancement, is one of several alternatives for noninvasive carotid evaluation. Screening examinations are routinely performed for carotid stenosis. Preoperative evaluations based on one or a combination of noninvasive tests have been proposed, although these proposals are the subject of ongoing controversy. Evaluation of the vertebral arteries is more difficult and less well studied: however, the increasing availability of therapies for posterior circulation atherosclerotic narrowing is resulting in increased interest in this problem.

Motion of the proximal renal artery during the cardiac cycle

In 48 hypertensive patients, the motion of the proximal renal artery during the cardiac cycle was quantified using two-dimensional quantitative flow (QF) measurements and automatic contour detection. Substantial translational motion was observed with an amplitude ranging from 1 to 4 mm. Since motion effectively reduces spatial resolution, the use of motion suppression techniques should be strongly considered for renal MR angiography. J. Magn. Reson. Imaging 2000;12:924-928.